FLUIDFORM INC

ACTON, MA · Biotech · Private

Platform for 3D printing thermoset polymers (silicones, epoxies, urethanes) using FRESH printing technology with support baths

fluidformbio.com →
Grants
$1.2M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Advanced manufacturing of a bioprosthetic collagen heart valve$255,369
Federal grantDepartment of Health and Human Services · Phase I · Advanced manufacturing of a bioprosthetic collagen heart valve$255,369
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Additive Manufacturing of Silicone Elastomers and Thermosets Using Freeform Reversible Embedding$249,644
Federal grantDepartment of Health and Human Services · Phase I · Bioprinted Human Ventricles for In Vitro Modeling of Cardiac Arrhythmias$228,550
Federal grantDepartment of Health and Human Services · Phase I · Bioprinted Human Ventricles for In Vitro Modeling of Cardiac Arrhythmias$228,550
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2776Recursion Pharmaceuticals, LLC—$466M
2777CARTESIAN THERAPEUTICS INC—$446M
2778Genetic Networks, LLC——
2779FLUIDFORM INC——
2780Tentarix——
2781Instil Bio, Inc.—$371M
2782Legend Biotech Corp—$350M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Nonstochastic Foam And Methods Of Manufacturing Thereofapplication
  • Nonstochastic Foam and Methods of Manufacturing Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.